🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/08/2003 | 40,31 | 43,27 | 37,06 | 42,11 | +3,97% | 15,41% | 947.400 |
| 06/08/2003 | 41,92 | 42,30 | 40,27 | 40,50 | -3,48% | 4,82% | 216.271 |
| 05/08/2003 | 44,92 | 45,33 | 41,85 | 41,96 | -6,58% | 7,75% | 270.827 |
| 04/08/2003 | 44,69 | 47,01 | 42,89 | 44,92 | +1,01% | 9,21% | 256.079 |
| 01/08/2003 | 48,10 | 49,03 | 44,43 | 44,47 | -8,19% | 9,57% | 243.576 |
| 31/07/2003 | 47,27 | 49,59 | 46,79 | 48,43 | +2,94% | 5,94% | 450.176 |
| 30/07/2003 | 50,90 | 52,55 | 46,56 | 47,05 | -7,57% | 11,76% | 410.902 |
| 29/07/2003 | 52,40 | 53,34 | 50,38 | 50,90 | -1,80% | 5,64% | 229.630 |
| 28/07/2003 | 52,36 | 53,34 | 49,52 | 51,84 | -4,48% | 7,29% | 486.430 |
| 25/07/2003 | 54,83 | 56,44 | 53,26 | 54,27 | -0,89% | 5,80% | 210.207 |
| 24/07/2003 | 55,96 | 56,33 | 54,31 | 54,76 | -1,81% | 3,61% | 81.700 |
| 23/07/2003 | 55,55 | 55,92 | 52,93 | 55,77 | +0,61% | 5,39% | 168.208 |
| 22/07/2003 | 51,84 | 55,85 | 51,84 | 55,43 | +6,93% | 7,73% | 144.991 |
| 21/07/2003 | 52,03 | 53,45 | 51,47 | 51,84 | -0,72% | 3,81% | 87.577 |
| 18/07/2003 | 52,78 | 53,71 | 51,47 | 52,21 | -1,90% | 4,26% | 103.981 |
| 17/07/2003 | 54,95 | 54,95 | 52,33 | 53,23 | -3,20% | 4,77% | 152.793 |
| 16/07/2003 | 55,92 | 56,74 | 54,09 | 54,98 | -1,28% | 4,75% | 177.906 |
| 15/07/2003 | 57,45 | 58,95 | 54,65 | 55,70 | -2,75% | 7,49% | 375.049 |
| 14/07/2003 | 55,96 | 59,33 | 55,40 | 57,27 | +2,34% | 7,02% | 141.652 |
| 11/07/2003 | 58,47 | 58,58 | 55,96 | 55,96 | -3,86% | 4,48% | 125.568 |
| 10/07/2003 | 59,29 | 59,48 | 56,29 | 58,20 | -1,46% | 5,37% | 297.837 |
| 09/07/2003 | 56,18 | 59,51 | 54,57 | 59,06 | +5,13% | 8,79% | 279.590 |
| 08/07/2003 | 54,76 | 56,74 | 52,93 | 56,18 | +4,09% | 6,97% | 251.324 |
| 07/07/2003 | 51,58 | 57,01 | 51,58 | 53,97 | +4,64% | 10,52% | 634.922 |
| 03/07/2003 | 49,26 | 52,21 | 49,26 | 51,58 | +3,53% | 6,00% | 522.338 |
| 02/07/2003 | 50,83 | 50,87 | 48,92 | 49,82 | -2,13% | 3,83% | 326.317 |
| 01/07/2003 | 49,63 | 51,09 | 47,91 | 50,90 | +0,07% | 6,41% | 312.558 |
| 30/06/2003 | 50,72 | 51,32 | 49,07 | 50,87 | +0,67% | 4,43% | 343.416 |
| 27/06/2003 | 52,74 | 55,02 | 50,16 | 50,53 | -5,59% | 9,23% | 258.564 |
| 26/06/2003 | 51,13 | 53,90 | 51,13 | 53,52 | +3,32% | 5,42% | 216.913 |